Octopus (part 4): Involvement of people affected by MS with Susan Scott
Update: 2023-11-09
Description
Octopus is a new clinical trial for people living with progressive multiple sclerosis (MS), which is designed and run by the MRC Clinical Trials Unit at UCL. Thanks to its multi-arm multi-stage platform design, Octopus has the potential to transform the way treatments for progressive MS are tested. The trial is now open in the UK and will be recruiting participants for the next few years.
The podcast mini-series will explore the trial from different perspectives by talking to neurologists, MS experts and people affected by MS.
In the final part, we explore the role of people affected by MS in the Octopus trial. Susan Scott, a pharmaceutical publications specialist and Octopus patient representative, shares her involvement in the trial and explains how PPI has benefited Octopus so far.
-
For more information and to access the transcript: bit.ly/3S6FKP4
For questions or feedback on the series, message us at mrcctu.engage@ucl.ac.uk
As a listener, your opinion is very valuable to us. Please help us to improve the podcast in the future by filling in this short survey: forms.office.com/e/PjfjQ5Mn6g
The podcast mini-series will explore the trial from different perspectives by talking to neurologists, MS experts and people affected by MS.
In the final part, we explore the role of people affected by MS in the Octopus trial. Susan Scott, a pharmaceutical publications specialist and Octopus patient representative, shares her involvement in the trial and explains how PPI has benefited Octopus so far.
-
For more information and to access the transcript: bit.ly/3S6FKP4
For questions or feedback on the series, message us at mrcctu.engage@ucl.ac.uk
As a listener, your opinion is very valuable to us. Please help us to improve the podcast in the future by filling in this short survey: forms.office.com/e/PjfjQ5Mn6g
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
